Here is a list of the current clinical trials at Broward Health where we are actively enrolling patients. If you have any questions, please feel free to contact us.
ADULT CANCER RESEARCH TRIALS
- Lung
- FDI-213: A Prospective Collection of Peripheral Blood from Adults for CYFRA-21-1, SCC and NSE Assay Reference Range Determination
- Breast
- Alliance A212102: Blinded Reference Set for Multicancer Early Detection Blood Tests
- Alliance A191901: Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
- SWOG S2013: Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study
- Gynecologic
- GOG 3038: An Umbrella Study of INCMGA00012 Alone and in Combination with Other Therapies in Participants with Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)
- GOG-3083: A Phase III, Randomized Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma (ENGOT)
- Head and Neck
- EA3202: A Phase II/III Trial of Chemotherapy + Cetuximab vs. Chemotherapy + Bevacizumab vs. Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers
- The Efficacy of Topical Fibrin Sealant in the Reduction of Post-Operative Pain After Head and Neck Surgery
- Biospecimen Trials
- The Utility of Molecular Diagnostics from Cervicovaginal Sampling in Endometrial Cancer
- University of Arizona - Supportive Care Research Studies After Cancer Treatment (Protocol# 1711069340R2002)
- NSU and Broward Health Collaboration: Tissue Samples and Nucleotide Excision Repair Capacity to Evaluate the Nucleotide Excision Repair (NER) Capacity of Non-Tumor Adjacent (NTA) Tissue
- SERATRIALS - 18004: A Multi-Center Study for the Collection of Biospeciments for Research; Surplus Surgical Tissues and Surplus/Non-Surplus Biofluids for In-Vitro Research
- MT Group: Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients (Specimen Trial)
- MTG-022: Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients
CARDIOVASCULAR RESEARCH TRIALS
- AIM HIGHer: Assessment of Implantable CCM in the Heart Failure Group With Higher Ejection Fraction
- INTEGRA-D: Assessment of the Safety and Efficacy of Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects with Heart Failure and Reduced Ejection Fraction
NEUROLOGY RESEARCH TRIALS
- AL002: Assessment of Safety and Efficacy of Exablate Blood-Brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease
- Post-Stroke Follow-Up Telephone Call for Discharge Plan of Care Compliance
PEDIATRIC CANCER TRIALS
- Leukemia
- AALL1631: A Children’s Oncology Protocol for an International Phase III Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ph+ ALL Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbone
- AALL1731: A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)
- AALL1732: A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND# 133494, NSC# 772518) for Newly Diagnosed High-risk B-ALL; Risk-Adapted Post-induction Therapy for High-risk B-ALL, Mixed Phenotype Acute Leukemia and Disseminated B-LLy
- Neuroblastoma
- Renal/Kidney
- AREN03B2: A Children’s Oncology Group Protocol for Study of Kidney Tumors in Younger Patient
- Other
- ALTE05N1: A Children’s Oncology Protocol for Long-Term Follow-Up of Patients Who Have Participated in COG Studies
- APEC1621: A Children's Oncology Protocol for MATCH (Molecular Analysis for Therapy Choice) Examining Molecular Changes Using Genomic Sequencing Technologies in Refractory/Recurrent Tumors in Children and Adolescents
- AGCT1532: A Randomized Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-risk Metastatic Germ Cell Tumors
- APEC14B1: A Children’s Oncology Protocol for Project: EveryChild: A Registry, Eligibility Screening, Biology, and Outcome Study
- ACCL20N1CD: Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
- ALTE1631: A Randomized Web-Based Physicial Activity Intervention Among Children and Adolescents With Cancer
- DCP-001: Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
- AGCT1531: A Phase 3 Study of Active Surveillance for Low Risk and A Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
- ARTES2031: A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, nad Cyclophosphamide (VINO-AC) vs. Vincristine, Dactinomycin and Cyclophosphamide (VAC) Plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS)
- ANHL1931: A Randomized Phase 3 Trial of Nivolumab (NSC#748726 IND#125462) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma
- APAL2020SC: Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
- ARST2032: A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low Risk and Low Risk Negative Rhabdomyosarcoma